Skip to content
OpenCapital
Get started

Genesco GCO Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
North America81%+1.3%

Other financials

Income statement

See full
Revenue$487.0M+2.8%
Gross profit$228.9M+3.5%
Operating income-$15.4M+45.4%
Net income-$14.8M+30.2%
EPS (diluted)-$1.42+29.7%

Balance sheet

See full
Cash & equivalents$27.1M+24.7%
Total debt$575.7M-9.7%
Total equity$552.4M+5.8%
Total assets$1.4B-1.5%

Cash flow

See full
Operating cash flow-$102.8M-1.7%
CapEx$15.4M-18.4%
Free cash flow-$118.2M+1.5%

Valuation

See full
Market cap$385.86M+60.4%
Enterprise value$934.46M+9.1%
P/E19.6×—
P/S0.2×+0.1×

Profitability

See full
Gross margin46.3%-0.7pp
Operating margin1.2%+0.5pp
Net margin0.8%—
FCF margin3.5%+2.7pp

Returns & leverage

See full
Return on equity3.7%—
Debt / equity1×-0.2×
Current ratio1.8×-0.1×